Key facts and Forecast
Financial results of fiscal 2023
- Net sales decrease organically by 1.6% to € 21.0 billion
- EBITDA pre down organically by 9.0% to € 5.9 billion
- “Transitional year” 2023 characterized by demanding market conditions in Life Science and Semiconductor Materials
- Strong sales and earnings performance of Healthcare demonstrates benefits of diversified business model of the Group
- Stable dividend proposal: € 2.20 per share
Forecast for fiscal 2024
- Return to organic growth expected in 2024
- Sales and EBITDA pre: slight to moderate organic growth
Overview: business performance in fiscal 2023
| Fiscal 2023 (in € billion) | Change (in %, compared to 2022) | Organic change (in %, compared to 2022) |
|---|---|---|---|
Group net sales |
21.0 |
-5.6 |
-1.6 |
EBITDA pre |
5.9 |
‑14.2 |
‑9.0 |
Life Science sales |
9.3 |
-10.6 |
-7.9 |
Healthcare sales |
8.1 |
2.7 |
8.5 |
Electronics sales |
3.7 |
‑8.8 |
‑5.1 |
We delivered solid results in a transitional year 2023 despite difficult market conditions. Now, we are fully focusing on gradually returning to growth during fiscal 2024.
Results & Beyond: Our CEO Speaks
Our CEO Belén Garijo comments on the fiscal 2023 results.
-
![Brochure title]()
Annual Report 2023
Download (PDF) Online ReportDetailed information about the development of our business in fiscal 2023.
ADDITIONAL INFORMATION
Downloads for the Media
Additional Downloads
- Presentation for Analysts (PDF)
- Financial Statement (XLS)
- Financial Statement (PDF)
- Regional Sector Sales (XLS)
- Summary (PDF)
Conference calls for the media and analysts
- The annual press conference and the conference call for analysts are available as a recording
Related News
View All News-
Press Releases
Fiscal 2023: Proven Resilience During Transitional Year
The Group demonstrated the robustness of its diversified business model in a challenging market environment.
2024/03/07
Upcoming Events
View All Events26 Apr 2024
Annual General Meeting 2024
The Annual General Meeting of Merck KGaA, Darmstadt, Germany will take place on April 26, 2024.
Our Q1 2024 results will be published on May 15, 2024, at 7 a.m. (CET). Our conference call for the media will take place at 09:30 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).
Annual Reports Archive
Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price